Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Safety and pharmacokinetics of GSK3494245, a highly selective Leishmaniasis kinetoplastid proteasome inhibitor for the treatment of visceral leishmaniasis: A Phase 1, randomized, single ascending dose escalation study in healthy participants.
Journal: PLoS neglected tropical diseases
Published: July 11, 2025
A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers.
Journal: British journal of clinical pharmacology
Published: August 11, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026